P3.15-012 Surgical Outcome in Early Stage Small Cell Lung Cancer
نویسندگان
چکیده
منابع مشابه
Surgical treatment of early-stage non-small-cell lung cancer
Surgical resection remains the standard of care for functionally operable early-stage non-small-cell lung cancer (NSCLC) and resectable stage IIIA disease. The role of invasive staging and restaging techniques is currently being debated, but they provide the largest biopsy samples which allow for precise mediastinal staging. Different types of operative procedures are currently available to the...
متن کاملSurgical Management of Stage IIIA Non-Small Cell Lung Cancer
According to the eighth edition of the tumor-node-metastasis classification, stage III non-small cell lung cancer is subdivided into stages IIIA, IIIB, and IIIC. They represent a heterogeneous group of bronchogenic carcinomas with locoregional involvement by extension of the primary tumor and/or ipsilateral or contralateral lymph node involvement. Surgical indications have not been definitely e...
متن کاملSurvival in untreated early stage non-small cell lung cancer.
BACKGROUND The aim of this study was to determine the survival of untreated stage I and II in non-small cell lung cancer (NSCLC) patients. PATIENTS AND METHODS A retrospective analysis of medical charts of all patients diagnosed with early stage NSCLC, between January 1990 and December 2001, was conducted and patients who were not treated were identified. Data on patient's age, gender, stage ...
متن کاملDisparities in surgical treatment of early-stage non-small-cell lung cancer.
This study involved 1,564 black or white patients diagnosed in 1992 to 1997 with non-small-cell lung cancer, reported to the population-based Connecticut Tumor Registry, who were linked with a statewide hospital discharge database that provided information on comorbid conditions. While only 11.4 percent of patients did not receive surgical treatment (lung resection), this proportion increased w...
متن کاملOverexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer.
This prospective study was performed to assess the impact of matrix metalloproteinase (MMP) 2 expression on the clinical course of patients with operable non-small cell lung cancer (NSCLC). Specimens of 193 consecutive patients with completely resected NSCLC were examined for MMP-2 expression by immunohistochemical staining with a polyclonal antibody. Homogeneous immunostaining of cancer cells ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Thoracic Oncology
سال: 2017
ISSN: 1556-0864
DOI: 10.1016/j.jtho.2017.09.1802